Clinical Trial Update: Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients With Low CD4+ Counts (SILCAAT Study) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether adding Interleukin-2 to antiretroviral therapy improves outcomes for HIV patients with low CD4+ counts; results posted after co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Antiretroviral therapy
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: University of Minnesota | Conditions: HIV Infection | Phase 3 | Status: COMPLETED | Results posted: 2010-12-13